FDA Drug recall D-0818-2020
Tadalafil 20 mg Troche
- FDA Drug
- Class II
- terminated
- Published 2020-02-05
On 2020-02-05 the FDA classified a Class II recall of Tadalafil 20 mg Troche by Mprx, citing labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0818-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-12-18 |
| Published | 2020-02-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Mprx |
| Distribution | TX |
Product
Tadalafil 20 mg Troche
Reason
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Identifiers
| code_info | Lots: 61137:42 Use by: 03/08/2020; 61324:99 Use by: 04/04/2020; 60856:42 Use by: 02/02/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0818-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.